Carolina E Price, MPA
she/her/hers
Cards
About
Profile Summary
Research
Publications
2026
P-356. Preliminary Experience using a Pharmacist-led Intervention to Support Injectable HIV Treatment for Women with Health-related Social Needs
Meyer J, Price C, Tracey D, Hernandez A, Tucker N, Thayer B, Barakat L. P-356. Preliminary Experience using a Pharmacist-led Intervention to Support Injectable HIV Treatment for Women with Health-related Social Needs. Open Forum Infectious Diseases 2026, 13: ofaf695.574. PMCID: PMC12792851, DOI: 10.1093/ofid/ofaf695.574.Peer-Reviewed Original ResearchHealth-related social needsPharmacist-led interventionsClinic-based pharmacistsHigh-risk substance usePatient-reported outcomesSocial needsHealth equityPharmacist visitIntervention engagementVisit adherenceAnalysis of baseline characteristicsHIV diagnosisPoor living conditionsHIV clinicHIV treatmentHousing instabilityAlcohol misuseFood insecurityEligibility evaluationStudy interviewsNNRTI resistanceViiV HealthcareCAB/RPVSubstance useViral load
2025
Evaluation of a “one-stop shop” for integrated harm reduction and primary care for people who inject drugs
Ibrahim N, Jones S, Rich K, Alvarez L, Price C, Kil N, Altice F, Meyer J. Evaluation of a “one-stop shop” for integrated harm reduction and primary care for people who inject drugs. PLOS ONE 2025, 20: e0337528. PMID: 41270056, PMCID: PMC12637901, DOI: 10.1371/journal.pone.0337528.Peer-Reviewed Original ResearchConceptsSyringe service programsHarm reduction strategiesHarm reductionPrimary healthcare servicesDepartment of Public HealthConnecticut Department of Public HealthAge of clientsService delivery sitesSyringe services program clientsService programsHarm reduction programsInjected drugsVolume of clientsPrimary careSocial characteristicsHealthcare servicesOverdose educationPatient educationNaloxone distributionReduction strategiesSyringe servicesIBM SPSS StatisticsDisease preventionDemographic characteristicsReduction programsRationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study
Meyer J, Brunson S, Price C, Mulrain M, Nguyen J, Altice F, Kyriakides T, Cropsey K, Eaton E. Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study. Addiction Science & Clinical Practice 2025, 20: 4. PMID: 39825419, PMCID: PMC11742507, DOI: 10.1186/s13722-024-00534-x.Peer-Reviewed Original ResearchConceptsCriminal legal systemOpioid use disorderLegal systemStandard of careStructural barriersUse disorderEnhanced standard of careRates of opioid use disorderDelivery of PrEPPre-exposure prophylaxisWomen's abilityRandomized clinical trialsLife-saving interventionsRandomized Controlled TrialsHealth disparitiesImplementation outcomesPrEP initiationPreventive servicesClinical outcomesIntegrated deliveryFollow-upDelivery modelsClinical trialsDecision aidPrEP
2024
A PrEP decision aid for women survivors of intimate partner violence: Task-shifting implementation to domestic violence service settings
Meyer J, Lazarus E, Phillips K, Watts Z, Duroseau B, Carlson C, Price C, Kershaw T, Willie T. A PrEP decision aid for women survivors of intimate partner violence: Task-shifting implementation to domestic violence service settings. PLOS ONE 2024, 19: e0310837. PMID: 39288155, PMCID: PMC11407614, DOI: 10.1371/journal.pone.0310837.Peer-Reviewed Original ResearchConceptsIntimate partner violence survivorsIntimate partner violenceAgency staffPartner violenceHIV prevention interventionsService agenciesDomestic violence service agenciesSurvivors of intimate partner violenceWomen survivors of intimate partner violenceDomestic violence agenciesFemale IPV survivorsService delivery mechanismsHIV pre-exposure prophylaxisTrauma responseIPV survivorsPre-exposure prophylaxisPreventive health needsWomen survivorsPreventive interventionsQualitative interviewsStructural barriersAid interventionsHealth needsConsolidated Framework for Implementation ResearchAgenciesImpact of COVID-19 on women living with HIV who are survivors of intimate partner violence
Zhang X, Price C, Pope A, Sullivan T, Meyer J. Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence. BMC Public Health 2024, 24: 1352. PMID: 38769576, PMCID: PMC11103830, DOI: 10.1186/s12889-024-18862-7.Peer-Reviewed Original ResearchConceptsIntimate partner violenceIntimate partner violence exposureLifetime intimate partner violencePartner violenceRates of intimate partner violenceSurvivors of intimate partner violenceIntimate partner violence survivorsSubstance usePhysical healthMental healthImpact of COVID-19Experiences of WLWHImpact domainsHIV care engagementSubstance use problemsConcurrent mental healthIPV survivorsSample of WLWHCOVID-19-related impactsHealth emergency periodMultivariate linear regression modelPrimary explanatory variablePearson chi-square testCare engagementGroup of women
2023
Experience delivering an integrated service model to people with criminal justice system involvement and housing insecurity
Baker O, Wellington C, Price C, Tracey D, Powell L, Loffredo S, Moscariello S, Meyer J. Experience delivering an integrated service model to people with criminal justice system involvement and housing insecurity. BMC Public Health 2023, 23: 222. PMID: 36732685, PMCID: PMC9892679, DOI: 10.1186/s12889-023-15108-w.Peer-Reviewed Original ResearchConceptsCriminal justice systemJustice systemService deliveryCriminal justice system involvementJustice system involvementCriminal justice involvementIntegrated service deliveryPrior felony convictionsPrison/jailHousing programsHousing insecurityHousing instabilityNeeds of peopleFelony convictionsSocial resourcesIntensity of contactJustice involvementContact encountersComprehensive needs assessmentDirect servicesSubstance use issuesHomelessnessStudy interviewsMost participantsUse issues
2022
A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks
Meyer JP, Price CR, Ye Y, Qin Y, Tracey D, Demidont AC, Melbourne K, Altice FL. A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks. AIDS And Behavior 2022, 26: 3807-3817. PMID: 35672552, DOI: 10.1007/s10461-022-03709-2.Peer-Reviewed Original ResearchConceptsTDF/FTCPrEP care continuumPre-exposure prophylaxisPrimary care providersPrEP demonstration projectRisk network membersNon-Hispanic whitesCisgender womenOutreach modelRespondent-driven samplingPrEP awarenessCommunity outreach modelEnrolled participantsMean ageClinical criteriaIndex participantsCare continuumHIV preventionSocial comorbiditiesCare providersKey populationsPrEPSubstance useMedical insuranceWomenOverlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders
Gibson B, Hoff E, Haas A, Adams ZM, Price CR, Goddard-Eckrich D, Sheth SS, Dasgupta A, Meyer JP. Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders. Women's Health 2022, 18: 17455065211070543. PMID: 35023410, PMCID: PMC8771433, DOI: 10.1177/17455065211070543.Peer-Reviewed Original ResearchConceptsSubstance use disordersPre-exposure prophylaxisUse disordersHIV preventionReproductive healthReproductive health service utilizationHigh HIV risk behaviorHealth service utilizationUnique health issuesCross-sectional evaluationHIV risk behaviorsHigh unmet needReproductive health behaviorsReproductive health needsConcurrent clinical trialsForm of contraceptionTime of assessmentPregnancy intentionReproductive ageClinical trialsUnintended pregnancyService utilizationCriminal justice involvementDrug treatmentContraceptive use
2021
Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice
Hoff E, Rutledge R, Gibson BA, Price CR, Gallagher C, Maurer K, Meyer JP. Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice. Journal Of Correctional Health Care 2021, 28: 22-31. PMID: 34762498, PMCID: PMC8825570, DOI: 10.1089/jchc.19.11.0082.Peer-Reviewed Original ResearchConceptsCriminal justice systemJustice systemHispanic/Latina ethnicityPartner violenceIncarcerated womenPrEP eligibilityPartner violence exposureViolence exposurePrEP attitudesProphylaxis implementationPreexposure prophylaxisImplementation effortsRisk perceptionLatina ethnicityMultivariate modelViolencePrEPPolicyProbationWomenEligibilityEthnicityAttitudesPracticePerceptionPreference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders
Meyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders. Patient Preference And Adherence 2021, 15: 1913-1927. PMID: 34511887, PMCID: PMC8420782, DOI: 10.2147/ppa.s315543.Peer-Reviewed Original ResearchSubstance use disordersPersonal HIV riskHIV preventionAddiction treatment servicesHIV riskUse disordersTreatment servicesPatient-centered decision aidAwareness of PrEPHIV prevention cascadeInitiation of PrEPPre-exposure prophylaxisOpioid use disorderStandard of careDecision aidAlcohol use severityHalf of participantsAddiction treatment programsDA participantsPrevention cascadePrimary outcomeIndependent correlatesHigh riskDecisional preferencesHigher alcohol use severity
Academic Achievements & Community Involvement
News
Get In Touch
Contacts
Academic Office Number
Office Fax Number
Mailing Address
J. Meyer Lab
270 Congress Ave
New Haven, CT 06519
United States
Locations
YCCR Storefront Office
Lab
270 Congress Avenue, Rm 107
New Haven, CT 06519
Clinical Inquiry
203.499.8075